Literature DB >> 17072642

Aortic rhythmic wrinkling in youth: the PDAY study.

Dana A Troxclair1, Beth A Schmidt, Edward E Herderick, Donald A Boudreau, Gray T Malcom, Jack P Strong.   

Abstract

Transverse, white-streak 'wrinkles' in the aorta were first described as Querlinien (cross lines) or Wellenlinien (wave lines) in the German literature in the early 20th century. These rhythmic structures were previously thought to be artifacts of stretching and shrinkage of the aorta. Not until the 1970s was it proposed that the areas of rhythmic wrinkling (RW) might be part of the process of atherosclerosis. We analyzed 2,650 aortas from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study for prevalence, extent, and topographical distribution of these areas of RW. Furthermore, we investigated the possible relationship of RW to atherosclerotic sudanophilic stained 'fatty streaks' and elevated intimal lesions called 'raised lesions' (RL). This study provides evidence that (1) the prevalence of RW is fairly high in the aorta and occurs in a specific distribution in both the thoracic and abdominal aorta; (2) RW seems to precede the development of RL, with RL occurring in the same topographical areas as RW; and (3) RW may be associated with the subsequent development of advanced atherosclerosis, particularly raised lesions.

Entities:  

Mesh:

Year:  2006        PMID: 17072642     DOI: 10.1007/s00428-006-0262-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  15 in total

1.  Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

Authors:  H C McGill; C A McMahan; A W Zieske; G D Sloop; J V Walcott; D A Troxclair; G T Malcom; R E Tracy; M C Oalmann; J P Strong
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

2.  The natural history of atherosclerosis: the early aortic lesions as seen in New Orleans in the middle of the of the 20th century.

Authors:  R L HOLMAN; H C McGILL; J P STRONG; J C GEER
Journal:  Am J Pathol       Date:  1958 Mar-Apr       Impact factor: 4.307

3.  Role of "wave line" (Doerr; Wellenlinie) of aorta in atherosclerosis.

Authors:  A Tanimura; T Cho; Y Saito; T Nakashima
Journal:  Angiology       Date:  1986-04       Impact factor: 3.619

4.  [Rhythmic structures of the aortic intima].

Authors:  A M Vikhert; V S Zhdanov
Journal:  Arkh Patol       Date:  1970

5.  Role of rhythmic structures of aortic intima in the development of atherosclerosis.

Authors:  A M Vikhert; V S Zhdanov
Journal:  Zentralbl Allg Pathol       Date:  1989

6.  Rhythmic structures and atherosclerosis in the aorta.

Authors:  A M Vikhert; N H Sternby; A M Livshits; J Dusková
Journal:  Atherosclerosis       Date:  1994-04       Impact factor: 5.162

Review 7.  A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

Authors:  H C Stary; A B Chandler; R E Dinsmore; V Fuster; S Glagov; W Insull; M E Rosenfeld; C J Schwartz; W D Wagner; R W Wissler
Journal:  Circulation       Date:  1995-09-01       Impact factor: 29.690

8.  Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

Authors: 
Journal:  Arterioscler Thromb       Date:  1993-09

9.  Surface characteristics of normal and atherosclerotic human arteries including observations suggesting interaction between flow and intimal morphology.

Authors:  D W Crawford; R Barndt; L H Back
Journal:  Lab Invest       Date:  1976-05       Impact factor: 5.662

Review 10.  Natural history and risk factors for early human atherogenesis. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.

Authors:  J P Strong
Journal:  Clin Chem       Date:  1995-01       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.